STAT News reports:
Rick Bright, the ousted head of the Biomedical Advanced Research and Development Authority, has filed a formal whistleblower complaint alleging he was involuntarily transferred to a lower position at the National Institutes of Health because he raised concerns about the Trump administration’s Covid-19 response and about nepotism in the Department of Health and Human Services.
Among the most explosive accusations: Bright’s complaint alleges he was pressured by HHS Secretary Alex Azar to allow the distribution of hydroxychloroquine, a malaria drug, unproven as a Covid-19 treatment that has nevertheless been championed by President Trump. According to the complaint, Bright worked “frantically,” alongside top Food and Drug Administration official Janet Woodcock to resist a plan to distribute the drug widely.
Read the full article.
Dr. Rick Bright, the ousted director of the office involved in developing a coronavirus vaccine, formally filed an extensive whistleblower complaint today alleging his early warnings about the coronavirus were ignored. @Kevinliptakcnn @JDiamond1 https://t.co/GRulH7tRiC
— Kaitlan Collins (@kaitlancollins) May 5, 2020
Whistleblower on the record—#RickBright—files complaint.
“Trump administration was warned repeatedly in mid January that it would have a critical shortage of surgical masks needed to combat coronavirus. But it failed to take action…”
— Ryan Goodman (@rgoodlaw) May 5, 2020
It’s official: Dr. Rick Bright has filed a complaint with the Office of Special Counsel. He alleges he was reassigned to a lesser role because he resisted political pressure to allow widespread use of hydroxychloroquine, a malaria drug favored by Trump. https://t.co/j2UgbwTwM1
— Kyle Griffin (@kylegriffin1) May 5, 2020
Breaking news: STAT has the Rick Bright whistleblower complaint and it is JUICY. https://t.co/aSaQg3OsLq
— Nicholas Florko (@NicholasFlorko) May 5, 2020